Long-Term Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nonintervened Nonculprit Coronary Lesions

Park, Mahn‐Won; Seung, Ki‐Bae; Kim, Pum-Joon; Park, Hun‐Jun; Yoon, Seug Yun; Baek, Joo-Yeoul; Koh, Yoon Seok; Jung, Hae-Ok; Chang, Kiyuk; Kim, Hee-Yeoul; Baek, Sang Hong

doi:10.1016/j.amjcard.2009.04.052

Cited by 22 publications

(32 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Park et al reported that several clinical factors such as the number of significantly stenosed coronary arteries, and a poor lipid profile were important predictors of non-culprit coronary lesion progression [2]. This finding indicated that the improvement of the lipid profile is one of the important points for preventing adverse events associated with a non-target vessel.…”

mentioning

confidence: 92%

“…Criteria for inclusion in the ChD-SAH group were the above items 1 and 2 plus one of the following; 3) systolic blood pressure N140 mm Hg or diastolic blood pressure N90 mm Hg at presentation; 4) a documented medical history of SAH or patients confirmation of previous treatment for SAH on admission at the Outpatient Cardiomyopathy Service in the case systemic arterial pressure was normal at presentation, but with patients receiving antihypertensive therapy [2]. Table 1 Baseline characteristics of the study population.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Lower frequency of non-target lesion intervention in post-successful percutaneous coronary intervention patients with an LDL to HDL cholesterol ratio below 1.5

Fukuda

Miura

Tsuchiya

et al. 2011

International Journal of Cardiology

View full text Add to dashboard Cite

mentioning

confidence: 92%

mentioning

confidence: 99%

Lower frequency of non-target lesion intervention in post-successful percutaneous coronary intervention patients with an LDL to HDL cholesterol ratio below 1.5

Fukuda

Miura

Tsuchiya

et al. 2011

International Journal of Cardiology

View full text Add to dashboard Cite

“…16 However, the rate of progression of clinical nontarget lesions requiring PCI at 1 year was lower than that in unselected patients with CAD. 14,17 The number of diabetic patients who had clinical nontarget lesion progression requiring PCI may have been underestimated because patients who died and had MI within 1 month after baseline PCI were excluded. These cardiovascular events may be caused by nontarget lesions progression.…”

Section: Rates Progression Of Clinical Nontarget Lesions Requiring Pcimentioning

confidence: 99%

“…12,13 Nontarget coronary lesions were defined as vessels with <50% diameter stenosis. 14,15 Nontarget lesion PCI was defined as clinically driven PCI of a previously nonintervened nontarget lesion. Clinically driven PCI referred to PCI associated with presence of ischemic symptoms or a positive functional ischemic study in the presence of 50% diameter stenosis.…”

mentioning

confidence: 99%

Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation

et al. 2015

View full text Add to dashboard Cite

Little is known about clinically driven percutaneous coronary intervention (PCI) rates and predictors for progression of nontarget lesions in diabetic patients who have undergone drug-eluting stent (DES) implantation. We retrospectively analyzed the clinical and angiographic data of 2187 diabetic patients undergoing DES implantation. The cumulative rate of nontarget lesion PCI was 6.3% at 1 year, 14.3% at 2 years, and 19.8% at 3 years. The independent predictors of need for clinically driven PCI in patients with diabetes mellitus after DES implantation included obesity (odds ratio [OR] 2.303, 95% confidence interval [CI] 1.657-3.199, P < .001), low levels of high-density lipoprotein cholesterol (OR 1.412, 95% CI 1.114-1.789, P ¼ .004), statin use (OR 0.669, 95% CI 0.454-0.986, P ¼ .042), insulin use (OR 1.310, 95% CI 1.030-1.665, P ¼ .027), and Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score (OR 1.061, 95% CI 1.045-1.077, P < .001) at baseline PCI. These findings may facilitate prediction of the risk of repeat revascularization and improve repeat revascularization rates in diabetic patients after DES implantation.

show abstract

“…New lesion PCI was defi ned as PCI for development of a coronary lesion which was not signifi cant at initial PCI but was requiring additional PCI due to an ischemic symptom and/or abnormal results of functional study including fractional fl ow reserve, radionuclide myocardial perfusion imaging using exercise or pharmacological stress, and treadmill exercise testing. [14][15][16] Statistical analysis: In terms of patient background, the categorical and consecutive data were presented as number (%) and mean ± standard deviation, respectively. We used one-way analysis of variance for comparisons of continuous variables.…”

mentioning

confidence: 99%

Recent Characteristics and Outcomes of Japanese Stable Angina Pectoris After Percutaneous Coronary Intervention

et al. 2013

View full text Add to dashboard Cite

SummaryThe mortality and morbidity of patients with stable angina pectoris (SAP) after percutaneous coronary intervention (PCI) in Japan differ from those in Western countries, although Japanese data are limited. We selected from the Shinken Database a single-hospital-based cohort of Japanese patients (n = 15,227) who visited The Cardiovascular Institute between 2004 and 2010 to undergo PCI. We followed-up the patients after PCI. A major adverse cardiac event (MACE) was defined as composite endpoints including all-cause death, acute myocardial infarction (AMI), and target-lesion revascularization (TLR). This study included 747 SAP patients (median follow-up period, 1,000 ± 703 days). The allcause mortality rate in SAP was 1.3% at 1 year, 2.7% at 3 years, and 6.1% at 5 years. The AMI rate was 0.5% at 1 year, 1.1% at 3 years, and 3.0% at 5 years, and the MACE rate was 14.0% at 1 year, 17.6% at 3 years, and 25.6% at 5 years. Moreover, new lesion PCI and heart failure admission continued to occur beyond 1 year after PCI without attenuation of their annual incidences up to 5 years. Multivariate analysis showed that poor left ventricular ejection fraction, chronic kidney disease (CKD), and absence of statin treatment were independent predictors of all-cause death of SAP patients after PCI. The results of the present study revealed the characteristics and long-term outcomes of Japanese SAP patients after PCI. The results of the present study suggest cardiorenal interaction and statin treatment play important roles in the long-term outcomes of Japanese CAD patients treated by PCI. (Int Heart J 2013; 54: 335-340)

show abstract

Long-Term Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nonintervened Nonculprit Coronary Lesions

Cited by 22 publications

References 22 publications

Lower frequency of non-target lesion intervention in post-successful percutaneous coronary intervention patients with an LDL to HDL cholesterol ratio below 1.5

Lower frequency of non-target lesion intervention in post-successful percutaneous coronary intervention patients with an LDL to HDL cholesterol ratio below 1.5

Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation

Recent Characteristics and Outcomes of Japanese Stable Angina Pectoris After Percutaneous Coronary Intervention

Contact Info

Product

Resources

About